Clinical Trial Update: A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial of CM326 for Chronic Rhinosinusitis With Nasal Polyps has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• CM326

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 1, Phase 2 | Status: COMPLETED